The structural mechanism of HIV-2 Vif antagonism of human APOBEC3H. [PDF]
Nat CommunNiu Y +5 more
europepmc +1 more source
HIV-2 infection as a comparative lens for functional HIV-1 remission. [PDF]
Front ImmunolArthur SE +7 more
europepmc +1 more source
Genotypic and Phenotypic Characterization of Replication-Competent HIV-2 Isolated from Controllers and Progressors. [PDF]
Viruses, 2023 Lungu C +6 more
europepmc +1 more source
Phenotypic impacts of treatment-selected mutations in HIV-2 protease on darunavir and lopinavir susceptibility: Evaluating genotypic HIV-2 drug resistance tools. [PDF]
PLOS Glob Public HealthRaugi DN +12 more
europepmc +1 more source
It Was Not the Perfect Storm: The Social History of the HIV-2 Virus in Guinea-Bissau. [PDF]
Trop Med Infect Dis, 2023 Varanda J, Santos JM.
europepmc +1 more source
Shaping the founders: naïve CD4 T cell heterogeneity in people with HIV-1 or HIV-2. [PDF]
Front ImmunolBadura R +13 more
europepmc +1 more source
Intrinsic resistance of HIV-2 and SIV to the maturation inhibitor GSK2838232. [PDF]
PLoS One, 2023 Smith RA +6 more
europepmc +1 more source
HIV-2 infection in Europe - persistence by migrant flows from West Africa but low spillover into the native population. [PDF]
Infez MedSoriano V +9 more
europepmc +1 more source
Are Confirmatory Assays Reliable for HIV-1/HIV-2 Infection Differentiation? A Multicenter Study. [PDF]
J Clin Microbiol, 2023 Guiraud V +9 more
europepmc +1 more source
Decreasing Deaths Among People with HIV [PDF]
About 1.2 million people are living with HIV in the United States. Improvements in HIV care and treatment have made it possible for people with HIV to live nearly as long as people who don\u2019t have HIV. Yet, in 2017 HIV was among the 10 leading causes
core